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Septic pelvic thrombophlebitis (SPT) is a rare, yet serious
complication that occurs in the postpartum or postoperative
time period. The frequency is varied, ranging from 1:500 to
2,000 cesarean deliveries and 1:9,000 vaginal deliveries.1–3
However, these data are variable across institutions and over
time at the same institution.1,4–6
SPT is considered when a woman presents with abdom-
inal or pelvic pain and continues to be febrile in the post-
partum period after 3 to 4 days of appropriate antibiotic
therapy and other infectious sources have been ruled out.7,8
Most often a diagnosis of exclusion, experts recommend that









Abstract Objective The objective of this study was to identify risk factors associated with the
development of septic pelvic thrombophlebitis (SPT).
Study Design This is a secondary case–control study of the Eunice Kennedy Shriver
National Institute of Child Health and Human Development Maternal-Fetal Medicine
Unit Network Cesarean Registry. SPTwas defined as suspected infectious thrombosis of
the pelvic veins, often persistent febrile illness in the setting of antibiotic therapy for
endometritis. Women with SPT were compared with those without SPT using descrip-
tive statistics. Logistic regression models estimated the association between selected
risk factors and SPT.
Results Of 73,087 women in the cohort, 89 (0.1%) developed SPT. Women with SPT
were more likely to be < 20 years old (33.7 vs. 10.6%, p < 0.001), black race (58.4 vs.
29.1%, p < 0.001), and nulliparous (51.1 vs. 23.3%, p < 0.001). Hypertensive disorders
of pregnancy (32.6 vs. 11.8%, p < 0.001) and multiple gestation (12.5 vs. 7.4%,
p ¼ 0.03) were also more common in women with SPT. In the multivariable regression
model, maternal age < 20, black race, multiple gestation, and preeclampsia were all
significantly associated with increased odds of SPT (adjusted odds ratio [aOR]: 1.96,
95% confidence interval [CI]: 1.22, 3.14; aOR: 2.6, 95% CI: 1.68, 4.02; aOR: 2.10, 95% CI:
1.13, 3.88; aOR: 2.91, 95% CI: 1.86, 4.57).
Conclusion SPT is a rare pregnancy complication. Our analysis confirmed known risk
factors (e.g., infections, cesarean delivery), and identified novel ones, including black
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in the pelvic veins on computed tomography (CT) scan.1,8
Risk factors commonly associated with SPT include cesarean
delivery, chorioamnionitis, and endometritis.8–10 However,
these studies are all single institution and thus have limited
numbers of women with SPT.
The purpose of this study is to describe the frequency of
SPT and to determine whether specific demographic, an-
tenatal, or delivery characteristics are associated with the
development of SPT. Finally, we sought to describe maternal
complications associated with SPT.
Methods
This is a case–control study of the Eunice Kennedy Shriver
National Institute of Child Health and Human Development
Maternal-FetalMedicine Unit Cesarean Registry. The original
study recruited 73,257womenwho delivered via cesarean or
vaginal birth after cesarean andwas conducted from 1999 to
2002 in 19 academic centers, and has been previously
published.11 Data collection was performed by trained chart
abstractors (nurses) who were blinded to delivery mode. For
the purposes of this secondary analysis, we included all
women from the original study who delivered at more
than 23 weeks. This study was reviewed by our local Institu-
tional Review Board (IRB) and deemed exempt from IRB
oversight, as we were provided a deidentified dataset on
which to conduct these analyses.
SPT was defined as a suspected infectious thrombosis of
the pelvic veins and/or persistent febrile illness in the setting
of antibiotic therapy for endometritis. We defined cases as
women with SPT. Controls were defined as women without
SPT. Risk factors examined included maternal demographic,
antenatal, and intrapartum characteristics. Maternal com-
plications of interest included: need for repeat laparotomy,
hysterectomy, wound complications, venous thromboembo-
lism (deep vein thrombosis [DVT] and pulmonary embolus
[PE]), readmission, and maternal death.
Demographic, antenatal, and intrapartum characteristics
of women with SPT were compared with those without SPT
to identify risk factors. Data analysis was performed by
Student’s t-test, Fisher’s exact, or Wilcoxon’s rank-sum test
as appropriate. Maternal complications were also compared
among women with and without SPT using bivariate analy-
sis. Logistic regression models were used to estimate odds
ratios (ORs) for the association between selected risk factors
and SPT. Stepwise regressionwith backward eliminationwas
performed to select an adjusted model. Main effects were
retained in the model if p < 0.2. Analyses were performed
using STATA (version 14, StataCorp, College Station, TX).
Results
Of the73,087womenin thestudy, 89 (0.12%)developedSPT.Of
these, 87 out of 89 (98%) occurred following cesarean delivery.
Women who developed SPT were more likely to be younger
than 20 years old, non-Hispanic black race, have public insur-
ance, and nulliparous (all p < 0.001) compared with women
who did not develop SPT (►Table 1). Pregestational diabetes
was not a risk factor for SPT in this population (p ¼ 0.52).
However, twin gestation and obesity were both significantly
associated with SPT (p ¼ 0.03 and p ¼ 0.02, respectively).
Womenwho developed SPTwere more likely to have labored,
had chorioamnionitis, delivered preterm < 32 weeks, and
delivered via cesarean delivery when compared with women
who did not develop SPT (all p ¼ 0.001 or less).
In the multivariable regression model, OR of SPT were
significantly increased among women delivering by cesarean
(aOR: 6.25, 95% CI: 1.94–20.1) and those with chorioamnio-
nitis (adjustedOR [aOR]: 4.8, 95%CI: 2.95–7.86). Non-Hispanic
black race,maternal age < 20 years, hypertensive disorders of
pregnancy, and twin gestation were also significantly asso-
ciated with increased odds of SPT (►Table 2).
SPTwas not associatedwith an increased need formechan-
ical ventilation or maternal death (►Table 3). Other morbid-
ities such as wound complications, DVT, and PEs were all
significantly more common among women with SPT com-
pared with those without (all p < 0.001). Repeat exploratory
laparotomy and peripartum hysterectomy were also more
common among women diagnosed with SPT (►Table 3).
Among women with SPT, more than one in five required a
bloodtransfusion, comparedwithonly2.4%ofwomenwhodid
not have SPT (►Table 3, p < 0.001).
Discussion
We found SPT to be uncommon, diagnosed in 0.1% of this
high-risk cohort, a frequency similar to previous reports.1–3
However, we did identify some novel risk factors for devel-
opment of SPT, including age younger than 20 years old, non-
Hispanic black race, and multiple gestation, and confirmed
known risk factors for SPT, including cesarean section and
chorioamnionitis. In addition, we found that women with
SPT are associated with other severe postpartum complica-
tions including blood transfusion, wound complications,
hysterectomy, and repeat laparotomy.
Others have attempted to identify risk factors for the devel-
opment of SPT. Preceding peripartum infections appear to be a
clear risk factor. Rouse et al identified SPT to be significantly
associated with chorioamnionitis, as did Isler et al.12,13 Gibbs
et al noted thatendometritis, specificallyafter cesareandelivery,
increased the incidence of SPT to 2%.10Another subset of studies
have identified endothelial dysfunction/damage as a preceding
risk factor. Isler et alwho found that 45%ofwomenwithSPThad
a hypertensive disorder of pregnancy, comparedwith 12 to 13%
of womenwithout SPT.12 Hypertensive disorders of pregnancy
are associated with underlying endothelial dysfunction, part of
Virchow’s triad, which may help explain its strong association
between SPTs.4,12 Diabetes and chronic hypertension, two dis-
orders not associated with endothelial damage, were not asso-
ciated with SPT in either our cohort nor that of Isler et al.12
Finally, other authors have queried if women who develop SPT
have some degree of underlying thrombophilia. In our cohort,
therewerehighratesofDVTandPEamong thewomenwithSPT.
This might also explain the association between SPT and
hypertensivedisordersofpregnancy, in thatwomenwithunder-
lying thrombophilias are more prone to develop preeclampsia
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Table 1 Demographic and intrapartum factors associatedwith septic pelvic thrombophlebitis inMFMUCesarean Registry (n ¼ 73,087)
Septic pelvic thrombophlebitis
n ¼ 89 (%)
No septic pelvic thrombophlebitis




< 20 30 (33.7) 7,719 (10.6) < 0.001
20–34 53 (59.6) 54,867 (75.2)
 35 6 (6.7) 10,412 (14.3)
Non-Hispanic black race 52 (58.4) 21,270 (29.1) < 0.001
Public insurance 36 (40.5) 15,389 (21.1) < 0.001
Nulliparous 45 (51.1) 16,880 (23.3) < 0.001
Pregestational diabetes 1 (1.1) 1,531 (2.1) 0.52
Chronic hypertension 3 (3.4) 1,851 (2.5) 0.62
Smoking 14 (15.7) 10,275 (14.1) 0.67
Body mass index  30 61 (72.6) 41,072 (60.1) 0.02
Twin gestation 12 (13.5) 5,362 (7.4) 0.03
Hypertensive disorders or pregnancy 29 (32.6) 8,577 (11.8) < 0.001
Intrapartum
Preeclampsia 29 (32.6) 8,577 (11.8) < 0.001
Cesarean delivery 87 (97.8) 59,755 (81.9) < 0.001
Chorioamnionitis 26 (29.1) 4,034 (5.5) <0.001
Labor 67 (75.3) 41,771 (57.2) 0.001
Gestational age at delivery (wk)
23–36 20 (22.7) 15,509 (21.3) 0.05
37–41 53 (60.2) 50,437 (69.2)
 42 15 (17.1) 6,896 (9.5)
Abbreviation: MFMU, Maternal-Fetal Medicine Unit.
Table 2 aOR for risk factorsassociatedwithdevelopmentof septic
pelvic thrombophlebitis in MFMU Cesarean Registry (n ¼ 73,054)
aOR (95% CI) p-Value
Maternal age (y)a
< 20 1.96 (1.22, 3.14) 0.006
 35 0.69 (0.29, 1.61) 0.39
Non-Hispanic black raceb 2.60 (1.68, 4.02) < 0.001
Cesarean deliveryc 6.25 (1.94, 20.1) 0.002
Chorioamnionitis 4.81 (2.95, 7.86) < 0.001
Hypertensive disorders
of pregnancy
2.91 (1.86, 4.57) < 0.001
Public insuranced 1.98 (1.28, 3.04) 0.002
Multiple gestation 2.10 (1.13, 3.88) 0.019
Labor 1.79 (1.06, 3.00) 0.029
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; MFMU,
Maternal-Fetal Medicine Unit.
aReferent group: age 20 to 34 years.
bReferent group: other race/ethnicities.
cReferent group: vaginal birth after cesarean.
dReferent group: other payer.
Table 3 Maternal complications associated with septic pelvic
thrombophlebitis in MFMU Cesarean Registry (n ¼ 73,087)
Septic pelvic
thrombophlebitis
n ¼ 89 (%)
No septic pelvic
thrombophlebitis
n ¼ 72,998 (%)
p-Value
Readmission 3 (3.3) 916 (1.3) 0.07
Mechanical
ventilation
7 (7.9) 207 (7.8) 0.99
Maternal
death




7 (7.9) 181 (0.3) < 0.001
Peripartum
hysterectomy
3 (3.3) 338 (0.5) < 0.001
Wound
complication
20 (22.5) 775 (1.1) < 0.001
Pulmonary
embolism
6 (6.7) 97 (0.1) < 0.001
Deep vein
thrombosis
8 (9.0) 138 (0.2) < 0.001
Endometritis 64 (71.9) 3,662 (5.0) < 0.001
Blood
transfusion
19 (21.4) 1,760 (2.4) < 0.001
Abbreviation: MFMU, Maternal-Fetal Medicine Unit.
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and possibly SPT as well.12,14 In reality, there are probably risk
multiple factors needed for the development of SPT, including
some combination of infection, inflammation, and thrombo-
philia involve. Data from this population by Hauth, examining
DVT and PE risk, also allude to this.15
These data provide a large, multicenter population-based
cohort of SPTwith uniform, prospective data collection. Due to
the multicenter nature of the study, the population is more
diverse, and thus, the results may be more applicable to the
general population than previous single-center studies. As a
large proportion of the women within this study underwent
cesarean delivery, a known risk factor for SPT, we were able to
better study a rare outcome. Finally, as the datawere rigorously
collectedby trainedstudynurses, theriskofobserverbias is low.
This study is not without limitations. The original study
definition of SPTused only clinical diagnostic criteria and did
not require imaging confirmation for diagnosis. Of the 89
women with SPT, 53 (60%) did have a CT scan, though the
indication for the CTscan is not available in the data. Thus,we
are unable to determine if cases of SPT were confirmed by
imaging. We are also limited by the temporality of maternal
complications in relation to the diagnosis of SPT, which
confounds the ability to identify a “risk factor” from a
“complication” in some instances. For example, it is un-
known if a woman with SPT and a blood transfusion first
received the blood transfusion, or was first diagnosed with
SPT. Thus, we can make associations but cannot determine
causality. In addition, this is a secondary analysis. Finally, due
to the relative rarity of maternal complications associated
with SPT, regression modeling was not possible.
In conclusion, this case–control study confirms known risk
factors for SPT including chorioamnionitis, hypertensive dis-
orders of pregnancy, and cesarean delivery. We also identify
additional risk factors associated with this serious medical
complication, including youngmaternal age, AfricanAmerican
race, and multiple gestation. In addition, we highlight an
association with postpartum complications, including blood
transfusion, PE, wound infection, and hysterectomy. However,
further studies are needed to confirm these associations.
Providers caring for women with multiple SPT risk factors
and persistent postpartum fevers should have a low threshold
to evaluate, and consider presumptive treatment for SPT.
Note
This article was presented in part at the 37th Annual
Society of Maternal Fetal Medicine Meeting in 2017, Las
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